Literature DB >> 30471891

Placenta Accreta Spectrum.

Alison G Cahill1, Richard Beigi1, R Phillips Heine1, Robert M Silver1, Joseph R Wax1.   

Abstract

Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial-myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.
Copyright © 2018 American College of Obstetricians and Gynecologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30471891     DOI: 10.1016/j.ajog.2018.09.042

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

1.  Prediction of placenta accreta spectrum in patients with placenta previa using clinical risk factors, ultrasound and magnetic resonance imaging findings.

Authors:  Valeria Romeo; Francesco Verde; Laura Sarno; Sonia Migliorini; Mario Petretta; Pier Paolo Mainenti; Maria D'Armiento; Maurizio Guida; Arturo Brunetti; Simone Maurea
Journal:  Radiol Med       Date:  2021-06-22       Impact factor: 3.469

2.  Associated factors of blood transfusion for Caesarean sections in pure placenta praevia pregnancies.

Authors:  Vitaya Titapant; Thananan Chongsomboonsuk
Journal:  Singapore Med J       Date:  2019-03-11       Impact factor: 1.858

3.  Placental thickness correlates with placenta accreta spectrum (PAS) disorder in women with placenta previa.

Authors:  Yan Li; Hailey H Choi; Ruth Goldstein; Liina Poder; Priyanka Jha
Journal:  Abdom Radiol (NY)       Date:  2021-01-02

4.  [Long non-coding RNAs show different expression profiles and display competing endogenous RNA potential in placenta accreta spectrum disorders].

Authors:  Shuzhen Wu; Huishan Zhang; Yan Liu; Rui Wang; Shaoxin Ye; Meng Zeng; Zhengping Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

Review 5.  Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum.

Authors:  Tianyue Zhang; Shaowei Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-30

6.  Peripartum Ηysterectomy: A Four-Year Obstetric and Anesthetic Experience in a Tertiary Referral Hospital in Greece.

Authors:  Michael Sindos; Konstantinos Kalmantis; Konstantinos Samartzis; Michail Diakosavvas; Andreas Kalampalikis; Konstantina Kalopita; Emmanouil Stamatakis; Dimitrios Valsamidis; George Daskalakis
Journal:  Cureus       Date:  2022-05-17

Review 7.  Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel.

Authors:  Jonathan L Hecht; Rebecca Baergen; Linda M Ernst; Philip J Katzman; Suzanne M Jacques; Eric Jauniaux; T Yee Khong; Leon A Metlay; Liina Poder; Faisal Qureshi; Joseph T Rabban; Drucilla J Roberts; Scott Shainker; Debra S Heller
Journal:  Mod Pathol       Date:  2020-05-15       Impact factor: 7.842

Review 8.  Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020.

Authors:  John C Kingdom; Sebastian R Hobson; Ally Murji; Lisa Allen; Rory C Windrim; Evelyn Lockhart; Sally L Collins; Hooman Soleymani Majd; Moiad Alazzam; Feras Naaisa; Alireza A Shamshirsaz; Michael A Belfort; Karin A Fox
Journal:  Am J Obstet Gynecol       Date:  2020-01-30       Impact factor: 8.661

9.  Prophylactic Intraoperative Uterine Artery Embolization During Cesarean Section or Cesarean Hysterectomy in Patients with Abnormal Placentation: A Systematic Review and Meta-Analysis.

Authors:  Cheng-Chun Yang; Yi-Chen Chou; Tian-Ni Kuo; Jyun-Yan Liou; Hua-Ming Cheng; Yu-Ting Kuo
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-19       Impact factor: 2.740

10.  Molecular Changes on Maternal-Fetal Interface in Placental Abruption-A Systematic Review.

Authors:  Monika Bączkowska; Magdalena Zgliczyńska; Jan Faryna; Ewa Przytuła; Błażej Nowakowski; Michał Ciebiera
Journal:  Int J Mol Sci       Date:  2021-06-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.